Vlad Coric
CIK 1704317 · Chief Executive Officer · last filed 2026-06-08
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$72.27M
Companies
5
Total Filings
40
Lifetime Open-Market Net
$28.52M
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| RPRX | Director | 15,343 | $54.87 | $841.9K | $0 | 3 | 2026-06-08 |
| BHVN | Chief Executive Officer | 3,006,673 | $11.28 | $33.92M | $26.52M | 29 | 2026-03-03 |
| MANE | Director | 390,514 | $96.07 | $37.52M | $2.00M | 1 | 2026-02-05 |
| Revance Therapeutics, Inc. (RVNC) Delisted | Director | 15,000 | $3.65 | $54.8K | $0 | 4 | 2025-02-06 |
| Biohaven Pharmaceutical Holding Co Ltd. (BHVNw) Delisted | Chief Executive Officer | 1,348,282 | — | — | $0 | 1 | 2022-10-03 |
Recent Filings · Page 2 of 4
40 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-05-03 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +15,000 | $0 | EDGAR |
| 2024-04-23 | BHVN | Buy (P) | +121,951 | $5.00M | EDGAR |
| 2024-04-05 | BHVN | Grant (A) | +694 | $0 | EDGAR |
| 2024-03-08 | BHVN | Grant (A) | +6,472 | $0 | EDGAR |
| 2024-01-10 | BHVN | Grant (A) | +16,168 | $0 | EDGAR |
| 2024-01-04 | BHVN | Grant (A) | — | $0 | EDGAR |
| 2023-11-06 | BHVN | Grant (A) | — | $0 | EDGAR |
| 2023-10-10 | BHVN | Buy (P) | +454,545 | $10.00M | EDGAR |
| 2023-05-05 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +589 | $0 | EDGAR |
| 2023-03-03 | Revance Therapeutics, Inc. (RVNC) Delisted | Grant (A) | +5,195 | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.